On September 4, 2026, Carlsmed, Inc.'s Board appointed Jeffrey Bertolini as Chief Operating Officer, effective September 8, 2026. Mr. Bertolini, age 60, previously served as Senior Vice President of Operational Excellence and Vice President of Advanced Manufacturing Technologies at the company. His annual base salary increased to $475,000 with a target cash incentive opportunity of 60% of his base salary. He was also granted 50,000 stock options on September 8, 2026. Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions.

Carlsmed, Inc. reported second quarter 2026 financial results on August 5, 2026, announcing revenue of $18.9 million, a 57% increase year-over-year from $12.1 million. The company raised its full-year 2026 revenue guidance to $74–$78 million, up from the previous range of $72–$77 million. Gross profit reached $14.5 million with a gross margin of 76.8%, while operating expenses increased to $25.6 million due to higher sales and marketing costs. Net loss widened to ($10.5) million compared to ($6.8) million in the prior year period, and adjusted EBITDA was ($8.6) million. The company highlighted a recent CMS ruling effective October 1, 2026, providing enhanced reimbursement for aprevo® lumbar procedures, and noted that surgeon adoption grew over 60% year-over-year. Carlsmed operates in the medical technology industry, pioneering AI-enabled personalized spine surgery solutions.